INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Bath & Body Works, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBWI

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. concerning allegations of securities fraud and unlawful business practices [2]. Financial Performance - Bath & Body Works reported a second quarter 2025 earnings per diluted share of $0.30, a decline of 55.8% year over year, and net income of $64 million, down 57.9% year over year [4]. - The company cut its full year guidance for earnings per diluted share by $0.03, adjusting it to a range of $3.28 to $3.53 [4]. - In the third quarter of 2025, Bath & Body Works experienced a 1% year over year decline in revenue, missing its guidance of 1-3% growth [6]. - Net income for the third quarter fell 26% to $77 million, and the company revised its full year guidance for net sales from a previously positive outlook to negative "high single digits" [6]. - Expected earnings per diluted share were cut from a range of $3.28 to $3.53 to "at least $2.83" [6]. Stock Performance - Following the second quarter results, Bath & Body Works' stock price fell by $2.18 per share, or 6.9%, closing at $29.36 [5]. - After the third quarter results, the stock price dropped by $5.22 per share, or 24.8%, closing at $15.82 [6]. Legal Context - Investors have until March 16, 2026, to request appointment as Lead Plaintiff in the class action if they purchased Bath & Body Works securities during the Class Period [2].

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Bath & Body Works, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBWI - Reportify